Updated Jul 16, 2026
McMinn Rachel is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $969K. Lifetime open-market sales: $74K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-30 | NGNE | Neurogene Inc. | S — Open-market sale | 3.4K | $22.07 | $74K |
| 2026-02-24 | NGNE | Neurogene Inc. | A — Grant or award | 25.9K | $0.00 | |
| 2024-11-25 | NGNE | Neurogene Inc. | P — Open-market purchase | 47.5K | $20.40 | $969K |
McMinn Rachel is a corporate insider — currently tracked as Chief Executive Officer, Director. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 1 open-market purchases ($969K) and 1 open-market sales ($74K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live McMinn Rachel profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.